Background: Oxidative stress, generating from betel quid (BQ) chewing, cigarette smoking, and alcohol drinking; regulating by antioxidant-oxidant enzymes and dietary antioxidants seems to play a role in oral carcinogenesis. Objective: We aimed to examine the association between antioxidant-oxidant gene polymorphisms (CYBA, MnSOD, MPO, GPX1 and CAT), oral habits, and dietary antioxidants with the risk of oral squamous cell carcinoma (OSCC). Design: A total of 381 pathologically proved primary OSCC cases and 598 healthy controls matched for age and sex were recruited between July 2003 and February 2008 in the hospital-based case-control study. Another 200 cancer-free controls frequency matched to 200 case patients on sex, age (¡Ó5 years), and pack-years of betel quid chewing. All subjects were interviewed to collect the data on socio-demographic variables, histories of BQ-chewing, tobacco smoking, alcohol drinking, and dietary antioxidant intake. Then, TaqMan assay were used to identify the genotype of functional or common allele tagging SNPs of each gene. The plasma total antioxidant capacities were measured by colorimetric assay. Results: Higher intakes of vitamin C, vitamin E and lycopene together with gene polymorphisms (SOD2, GPX1, and CYBA) were associated with a decreased risk for OSCC in a trend-related manner. The risk of OSCC associated with CYBA genotype was modified by alcohol (Pinteraction = 0.04). Significant interactions were observed between BQ-chewing and SOD2 V16A (Pinteraction = 0.001), MPO G-463A (Pinteraction = 0.006) and CAT C3261T (Pinteraction = 0.002). GPx1 polymorphism interact with vitamin C and lutein/zeaxanthin to modify the risk of OSCC, respectively (Pinteraction = 0.023 and 0.006). In the combined analysis, a preventive relation appeared with subjects with seven ¡§at risk genotype¡¨ (AOR, 0.62; 95% CI, 0.36-1.04) and those with three to six ones (AOR, 0.55; 95% CI, 0.33-0.94) compared with 8-9 ones in a trend-related manner (Ptrend = 0.042). It showed an interaction effect between BQ-chewing and the combination of antioxidant-oxidant gene polymorphisms with OSCC risk (Pinteraction = 0.001). The dose-dependent protective effect was related to the decreased numbers of ¡§at risk genotypes¡¨ in lower intake of vitamin E (AOR, 0.54; 95% CI, 0.27-1.11 for 7 ¡§at risk genotype¡¨; AOR, 0.44; 95% CI, 0.21-0.90 for 3-6 ¡§at risk genotype¡¨; Ptrend = 0.035), and in higher intake of vitamin C (AOR, 0.33; 95% CI, 0.13-0.82 for 7 ¡§at risk genotype¡¨; AOR, 0.31; 95% CI, 0.12-0.73 for 3-6 ¡§at risk genotype¡¨; Ptrend = 0.047) and lycopene (AOR, 0.48; 95% CI, 0.20-1.14 for 7 ¡§at risk genotype¡¨; AOR, 0.38; 95% CI, 0.16-0.93 for 3-6 ¡§at risk genotype¡¨; Ptrend = 0.049). In stratification of the numbers of ¡§at risk genotypes¡¨ of XRCC1 (XRCC1 R194W, R180H and R399B) for two groups (0-1 and 2-3 ¡§at risk genotype¡¨ of XRCC1), the decreased risk of OSCC was observed with the decreasing number of ¡§at risk genotype¡¨ in the antioxidant-oxidant genes (AOR, 0.34; 95% CI, 0.14-1.83 for 7 ¡§at risk genotype¡¨; AOR, 0.31; 95% CI, 0.14-0.74 for 3-6 ¡§at risk genotype¡¨; Ptrend = 0.032) among those with 0-1 ¡§at risk genotype¡¨ of XRCC1. Significant interactions between MPO G-463A and alcohol consumption (Pinteraction 0.035), as well as between CYBA and lycopene intake in relation to OSCC risk (Pinteraction 0.036) respectively were found in those matched on BQ-chewing. Different from general population, the significant decreased risk of OSCC was observed among 2-3 ¡§at risk genotypes¡¨ of XRCC1 with less ¡§at risk genotype¡¨ (1-4) in the antioxidant-oxidant genes (AOR, 0.45; 95% CI, 0.25-0.82). In addition, we observed that subjects with seven to nine ¡§at risk genotype¡¨ had significantly lower TAS level than those with less than 7 (P = 0.024) ones. Conclusion: Antioxidant-oxidant genes and dietary antioxidants play an important role in cancer prevention. Dietary antioxidant intakes, alcohol and BQ-chewing may modify the protective magnitude of antioxidant genes. The synergistic effect of dietary antioxidant intakes and antioxidant-oxidant gene polymorphisms may decrease the impact of smoking, drinking or BQ-chewing on susceptibility to OSCC.

Le Sélénium (Se) est un oligo-élément essentiel qui est incorporé dans une famille indispensable de protéines, les sélénoprotéines, sous la forme d’un résidu acide aminé rare, la sélénocystéine. Dans les études épidémiologiques, il apparait clairement que des faibles niveaux de sélénium dans les fluides biologiques sont associés avec (i) une augmentation du risque de cancers (colon, prostate, poumon) et de maladies cardiovasculaires, (ii) une altération de la fonction immunitaire et (iii) finalement une réduction de l’espérance de vie. Dans le génome humain, vingt-cinq gènes de sélénoprotéine ont été identifiés. Ces gènes expriment, de par la complexité de la régulation du génome, de nombreuses isoformes de chacun des 25 gènes pour constituer le sélénoprotéome. Quand la fonction est connue, ces protéines participent à des processus essentiels de défense antioxydante, d’homéostasie redox et de signalisation redox. Ces enzymes sont finement régulées par l’apport en sélénium et d’autres stimuli cellulaires. Pour comprendre la fonction et la régulation du sélénoprotéome humain, qui est exprimé à un niveau trace, il s’avère critique de développer une stratégie innovante basée sur une approche multidisciplinaire de détection et quantification du sélénium par différents outils de spectrométrie de masse élémentaire (ICP MS) et moléculaire (ESI-MS/MS). Tout d’abord, le sélénium possède un profil isotopique bien particulier avec six isotopes stables (74Se, 76Se, 77Se, 78Se, 80Se and 82Se) qui sert de signature dans nos analyses en ICP-MS ou en ESI-MS/MS. En parallèle, l’utilisation de sélénium isotopiquement enrichi permet également des marquages cellulaires en multiplexing. Ainsi, en couplant des méthodes de séparation en phase liquide (HPLC) ou en gel d’électrophorèse (IEF ou SDS-PAGE échantilloné par ablation laser) avec l’ICP MS, nous avons mis au point plusieurs méthodes permettant la détection de plusieurs sélénoprotéines de manière simultanée dans différentes lignées cellulaires. De plus, un médicament sélénié sous forme de triglycéride obtenu via un mélange d’huile de tournesol et de sélénite a été testé comme source de sélénium non toxique pouvant stimuler la production de sélénoprotéines. Plusieurs lignées cellulaires humaines cancéreuses et non-cancéreuses ont été expérimentées avec succès permettant de valider cette nouvelle source de sélénium dans la synthèse des sélénoprotéines. / Selenium (Se) is an essential trace element, which is incorporated as a rare aminoacid, selenocysteine, in twenty five selenoproteins, to constitute the selenoproteome. Selenoprotein family is one of the most important bioactive form of selenium in human health. Initially demonstrated in Kashin Beck and Keshan diseases, selenium deficiency is associated with several pathological conditions, including cancer, neurodegenerative diseases, immune and muscular disorders. Chronic selenium deficiency is hypothesized to decrease antioxidant defenses and redox regulatory pathways through a dysregulation of selenoprotein expression. We are interested in understanding the synthesis and regulation of human selenoproteins, which is critically dependent on the availability of adequate analytical methodology. To understand the function and regulation of human selenoproteome, which is expressed at a trace levels, it appears critical to develop innovative strategies based on a multidisciplinary approach to detect and quantify selenium by various elemental and molecular mass spectrometer tools. First, selenium has a particular isotopic profile with six stable isotope (74Se, 76Se, 77Se, 78Se, 80Se and 82Se) used as a signature in our analysis with ICP-MS or ESI-MS/MS. In parallel, the use of isotopically enriched selenium also allows cellular labelling and tracing of selenoproteins and other seleno-coupounds. By coupling liquid phase separation methods (HPLC) with specific mass spectrometry analytical tools, we have developed several methods for detecting several selenoproteins simultaneously in various human cell lines.

O selênio é um micronutriente essencial que apresenta ação antioxidante por meio de selenoproteínas, como a glutationa peroxidase 1 (GPX1). O polimorfismo PRO198LEU no gene em questão tem sido relacionado ao aumento do risco para alguns tipos de câncer, como o de mama e pulmão. Atualmente, o câncer de cabeça e pescoço é um importante problema de saúde pública no mundo e, inclusive, no Brasil. O objetivo do presente estudo foi avaliar eventual associação entre o polimorfismo GPX1 PRO198LEU e risco de câncer epidermóide da cavidade oral e orofaringe, bem como possível interação com utilização de tabaco e ingestão de álcool. O genótipo para o polimorfismo GPX1 PRO198LEU foi determinado pela técnica de PCR-RFLP (Reação em cadeia da polimerase - Polimorfismo no comprimento do fragmento de restrição) e seqüenciamento do DNA em 175 pacientes com câncer epidermóide da cavidade oral e orofaringe (grupo caso) integrantes de parte da casuística do Projeto Genoma Clínico do Câncer de Cabeça e Pescoço, e em 203 indivíduos sem a doença, internados nas enfermarias do Hospital Heliópolis (grupo controle). A freqüência do alelo de referência e do polimórfico foi de 0,72 e 0,28, respectivamente, em ambos os grupos. A freqüência dos genótipos encontrou-se em equilíbrio de Hardy-Weinberg nos grupos caso e controle. Não houve diferença estatisticamente significante (p>0,05) quanto à distribuição do genótipo para o polimorfismo GPX1PRO198LEU entre casos (50% PRO/PRO; 43% PRO/LEU e 7% LEU/LEU) e controles (51% PRO/PRO; 43% PRO/LEU e 6% LEU/LEU), não se verificando associação entre esse polimorfismo e risco para o câncer epidermóide da cavidade oral e orofaringe (Odds ratio = 1,02; 95% IC = 0,68-1,53; p = 0,51; homozigotos polimórficos e heterozigotos agrupados comparados a homozigotos de referência). Além disso, a utilização de tabaco ou ingestão de álcool não modificou a ausência de associação entre o polimorfismo GPX1 PRO198LEU e o câncer em questão (Utilização de tabaco maior que 20 pack years: Odds ratio = 0,94; 95% IC = 0,53-1,70; p = 0,49; Ingestão de álcool maior que 80g de etanol/dia: Odds ratio = 0,80; IC = 0,46-1,39; p = 0,26). Conclui-se que esse polimorfismo não aumenta o risco para o câncer epidermóide da cavidade oral e orofaringe. / Selenium is an essential micronutrient that presents antioxidant activity through selenoproteins such as glutathione peroxidase 1 (GPX1). PRO198LEU polymorphism in this gene has been associated with increased risk for some cancer types such as breast and lung cancers. Currently head and neck cancer is a major public health problem in the world and in Brazil. The aim of this study was to evaluate a possible association between GPX1 PRO198LEU polymorphism and risk of oral cavity and oropharyngeal squamous cell cancer. GPX1 PRO198LEU polymorphism genotype was determined by PCR-RFLP method (Polymerase chain reaction-Restriction fragment length polymorphism) and DNA sequencing in 175 patients with oral cavity and oropharyngeal squamous cell cancer (case group) from the Head and Neck Cancer Clinical Genome Project, and in 203 cancer-free individuals, hospitalized in the wards of Heliopolis Hospital (control group). The frequency of reference and polymorphic allele was 0.72 and 0.28, respectively, in both groups. The genotype distribution was in Hardy-Weinberg equilibrium in case and control groups. There was no statistically significant difference (p> 0.05) on the distribution of genotype for the GPX1 PRO198LEU polymorphism between cases (50% PRO/PRO, 43% PRO/LEU and 7% LEU/ LEU) and controls (51% PRO/PRO, 43% PRO/LEU and 6% LEU/LEU) and there was no association between this polymorphism and risk for oral cavity and oropharyngeal squamous cell cancer (odds ratio = 1.02, 95% CI = 0.68 to 1,53; p = 0.51; polymorphic homozygotes and heterozygotes combined compared with reference homozygotes). Furthermore, the use of tobacco or alcohol intake did not change the lack of association between the GPX1 PRO198LEU polymorphism and cancer risk (use of tobacco greater than 20 pack years: odds ratio = 0.94, 95% CI = 0.53 to 1,70, p = 0.49; alcohol intake greater than 80g etanol/day: Odds ratio = 0.80, CI = 0.46 to 1.39, p = 0.26). We conclude that this polymorphism does not increase the risk of oral cavity and oropharyngeal squamous cell cancer.

O selênio é um micronutriente essencial que apresenta ação antioxidante por meio de selenoproteínas, como a glutationa peroxidase 1 (GPX1). O polimorfismo PRO198LEU no gene em questão tem sido relacionado ao aumento do risco para alguns tipos de câncer, como o de mama e pulmão. Atualmente, o câncer de cabeça e pescoço é um importante problema de saúde pública no mundo e, inclusive, no Brasil. O objetivo do presente estudo foi avaliar eventual associação entre o polimorfismo GPX1 PRO198LEU e risco de câncer epidermóide da cavidade oral e orofaringe, bem como possível interação com utilização de tabaco e ingestão de álcool. O genótipo para o polimorfismo GPX1 PRO198LEU foi determinado pela técnica de PCR-RFLP (Reação em cadeia da polimerase - Polimorfismo no comprimento do fragmento de restrição) e seqüenciamento do DNA em 175 pacientes com câncer epidermóide da cavidade oral e orofaringe (grupo caso) integrantes de parte da casuística do Projeto Genoma Clínico do Câncer de Cabeça e Pescoço, e em 203 indivíduos sem a doença, internados nas enfermarias do Hospital Heliópolis (grupo controle). A freqüência do alelo de referência e do polimórfico foi de 0,72 e 0,28, respectivamente, em ambos os grupos. A freqüência dos genótipos encontrou-se em equilíbrio de Hardy-Weinberg nos grupos caso e controle. Não houve diferença estatisticamente significante (p>0,05) quanto à distribuição do genótipo para o polimorfismo GPX1PRO198LEU entre casos (50% PRO/PRO; 43% PRO/LEU e 7% LEU/LEU) e controles (51% PRO/PRO; 43% PRO/LEU e 6% LEU/LEU), não se verificando associação entre esse polimorfismo e risco para o câncer epidermóide da cavidade oral e orofaringe (Odds ratio = 1,02; 95% IC = 0,68-1,53; p = 0,51; homozigotos polimórficos e heterozigotos agrupados comparados a homozigotos de referência). Além disso, a utilização de tabaco ou ingestão de álcool não modificou a ausência de associação entre o polimorfismo GPX1 PRO198LEU e o câncer em questão (Utilização de tabaco maior que 20 pack years: Odds ratio = 0,94; 95% IC = 0,53-1,70; p = 0,49; Ingestão de álcool maior que 80g de etanol/dia: Odds ratio = 0,80; IC = 0,46-1,39; p = 0,26). Conclui-se que esse polimorfismo não aumenta o risco para o câncer epidermóide da cavidade oral e orofaringe. / Selenium is an essential micronutrient that presents antioxidant activity through selenoproteins such as glutathione peroxidase 1 (GPX1). PRO198LEU polymorphism in this gene has been associated with increased risk for some cancer types such as breast and lung cancers. Currently head and neck cancer is a major public health problem in the world and in Brazil. The aim of this study was to evaluate a possible association between GPX1 PRO198LEU polymorphism and risk of oral cavity and oropharyngeal squamous cell cancer. GPX1 PRO198LEU polymorphism genotype was determined by PCR-RFLP method (Polymerase chain reaction-Restriction fragment length polymorphism) and DNA sequencing in 175 patients with oral cavity and oropharyngeal squamous cell cancer (case group) from the Head and Neck Cancer Clinical Genome Project, and in 203 cancer-free individuals, hospitalized in the wards of Heliopolis Hospital (control group). The frequency of reference and polymorphic allele was 0.72 and 0.28, respectively, in both groups. The genotype distribution was in Hardy-Weinberg equilibrium in case and control groups. There was no statistically significant difference (p> 0.05) on the distribution of genotype for the GPX1 PRO198LEU polymorphism between cases (50% PRO/PRO, 43% PRO/LEU and 7% LEU/ LEU) and controls (51% PRO/PRO, 43% PRO/LEU and 6% LEU/LEU) and there was no association between this polymorphism and risk for oral cavity and oropharyngeal squamous cell cancer (odds ratio = 1.02, 95% CI = 0.68 to 1,53; p = 0.51; polymorphic homozygotes and heterozygotes combined compared with reference homozygotes). Furthermore, the use of tobacco or alcohol intake did not change the lack of association between the GPX1 PRO198LEU polymorphism and cancer risk (use of tobacco greater than 20 pack years: odds ratio = 0.94, 95% CI = 0.53 to 1,70, p = 0.49; alcohol intake greater than 80g etanol/day: Odds ratio = 0.80, CI = 0.46 to 1.39, p = 0.26). We conclude that this polymorphism does not increase the risk of oral cavity and oropharyngeal squamous cell cancer.

Le sélénium est un micronutriment essentiel pour des nombreux organismes vivants, y compris l’homme. Son rôle est lié à sa présence dans des sélénoprotéines sous forme d’un acide aminé, génétiquement encodé – la sélénocystéine. Il y a 25 sélénoprotéines encodées dans le génome humain. Leurs fonctions, la cinétique et la hiérarchie d'expression se trouvent au cœur des problématiques de recherche concernant le sélénium et la santé humaine. Il existe également un autre type de protéines où le sélénium est inséré par un remplacement partiel du soufre dans la méthionine mais aussi, potentiellement, dans la cystéine. Ces protéines suscitent l’intérêt dans les sciences de nutrition comme source de sélénium biodisponible dans l’alimentation naturelle et supplémentée. L'objectif de cette thèse a été la mise au point de méthodologies analytiques visant la spéciation du sélénium incorporé dans les protéines à l’échelle du protéome entier. Une procédure inédite a été développée pour la détection globale de protéines séléniées dans des gels d’électrophorèse bidimensionnelle par l’imagerie d’ablation laser ICP MS (spectrométrie de masse plasma à couplage inductif) permettant de s’affranchir de l’utilisation de l’isotope radioactif 75Se. Les autres avancées comprennent la mise en place d’un couplage robuste de HPLC capillaire avec l’ICP MS pour la détection des sélénopeptides dans des microvolumes de digestats trypsiques des protéines extraites du gel ainsi que la mise en place des protocoles d’identification des protéines séléniées par la spectrométrie de masse électrospray en tandem utilisant la trappe orbitale (Orbitrap). Les méthodes développées ont permis (i) la caractérisation de la part du protéome sélénié contenant la sélénocystéine chez la levure séléniée, (ii) l’identification des protéines majeures qui accumulent le sélénium dans le blé, et (iii) le dosage semi quantitatif et la caractérisation globale des sélénoprotéomes (GPx1, GPx4, TRxR1, TRxR2, Sel15kDa) dans les lignées cellulaires. / Selenium is an essential micronutrient for many living organisms including man. Its role is related to selenoproteins which contain genetically encoded selenocysteine. There are 25 selenoproteins encoded in the human genome. Their function, expression kinetics and hierarchy have been a topic of intense research in life sciences. There is another type of proteins which contain selenium inserted non-specifically by partly replacing sulphur in methionine and, potentially, cysteine. They are of interest in nutrition science as source of bio-available selenium in natural and supplemented foods. The goal of this Ph.D. was the development of methodologies for the analysis of selenium-containing proteins on the entire proteome scale. A novel procedure was developed for their global detection in 2D electrophoretic gels par laser ablation inductively coupled plasma mass spectrometry (ICP MS) imaging permitting to avoid the use of the radioactive 75Se. The other developments included (i) a robust capillary HPLC – ICP MS coupling allowing the detection of Se-containing peptides in microliter volumes of the digests of proteins extracted from the gel and (ii) protocols allowing the targeted identification of the Se-containing proteins by a parallel capillary HPLC - electrospray Orbitrap MS/MS. The methods developed allowed (i) the characterisation of the selenocystein-containing part of the selenoproteome of Se-enriched yeast, (ii) identification of the major Se-accumulating proteins in wheat, and (iii) semiquatitive analysis and global identification of the selenoproteomes (GPx1, GPx4, TRxR1, TRxR2, Sel15kDa) expressed in different human cell lines.

Orientador: Edson Luis Maistro / Resumo: Das sementes de Pentaclethra macroloba (Willd.) Kuntze, popularmente conhecida como Pracaxi, é possível a extração de um óleo que vem sendo utilizado no Brasil e em outros países para fins terapêuticos e cosméticos. Este vegetal é endêmico da região amazônica e frequentemente utilizado pela população ribeirinha como agente cicatrizante tópico, aplicado principalmente em parturientes e em picadas de serpentes, devido à sua ação antiofídica. Apesar do uso popular desse óleo, na literatura encontram-se poucos estudos avaliando seu potencial citotóxico e genotóxico. Frente a esta lacuna científica, o objetivo deste estudo foi investigar os efeitos deste óleo em células humanas HepG2/C3A in vitro, sob os aspectos de citotoxicidade, genotoxicidade, influência sobre o ciclo celular, apoptose e expressão de genes do metabolismo de xenobióticos e outras vias de sinalização celulares. Os testes do cometa e do micronúcleo foram utilizados na avaliação da genotoxicidade e mutagênese, citometria de fluxo na avaliação dos efeitos sobre o ciclo celular e apoptose, bem como a avaliação da expressão de alguns genes envolvidos nesses processos. Os resultados obtidos revelaram que o óleo não reduz a viabilidade celular nas concentrações de 31, 125 e 500 µg/mL. Nos ensaios do cometa e do micronúcleo, o óleo não apresentou efeitos genotóxico nas concentrações testadas. Além disso, a citometria de fluxo revelou que o óleo não induz apoptose nas células. A análise da expressão gênica revelou que, d... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: From the Pentaclethra macroloba (Willd.) Kuntze seeds, popularly known as Pracaxi, it is possible to extract an oil that is being used in Brazil and in other countries for therapeutic and cosmetic purposes. This plant is endemic to the Amazon region and is frequently used by the riverine population as a topical healing agent, applied mainly to parturients and snake bites due to its antiofidic action. Despite the popular use of this oil, there are few studies in the literature evaluating its cytotoxic and genotoxic potential. The objective of this study was to investigate the effects of this oil on human HepG2 / C3A cells in vitro, under the aspects of cytotoxicity, genotoxicity, influence on the cell cycle, apoptosis and expression of xenobiotic and other metabolism genes cellular signaling pathways. The comet and micronucleus tests were used in the evaluation of genotoxicity and mutagenesis, flow cytometry in the evaluation of effects on the cell cycle and apoptosis, as well as the evaluation of the expression of some genes involved in these processes. The results showed that the oil did not reduce cell viability at concentrations of 31, 125 and 500 μg / mL. In the comet and micronucleus tests, the oil had no genotoxic effects at the concentrations tested. In addition, flow cytometry revealed that the oil does not induce apoptosis in cells. Analysis of gene expression revealed that of all genes tested, those that underwent stimulation were responsible for the metabolism of x... (Complete abstract click electronic access below) / Doutor

Occupational exposure-related hearing loss is a significant health concern for affected workers. Organic solvent exposure has emerged as an important contributor to hearing loss. It is thought that hearing loss related to solvent and noise exposure is mediated by reactive oxygen species (ROS). The glutathione associated enzymes and the manganese superoxide dismutase enzymes (SOD2) are important components of the cochlear hair cellâs defense against oxidative stress. This study is aimed to determine whether polymorphisms within the glutathione S-transferases (GST) P1 and GSTM1, glutathione peroxidase 1 (GPX1), and SOD2 are associated with hearing status in solvent exposed factory workers. Genotypes for the GSTM1 + vs. null, GSTP1 Ile105Val, GPX1 Pro198Leu, SOD2 Val16Ala polymorphisms along with hearing status were determined in factory workers exposed to organic solvents. Hearing tests consisted of pure tone audiometric (PTA) thresholds from 3-6 kHz and distortion product otoacoustic emissions (DPOAEs) for 3-6 kHz. Bivariate and multivariate regression analysis was undertaken to assess for association between polymorphisms and hearing outcomes. The GSTP1 Val/Ile genotype at position 105 was associated with higher PTA thresholds (β=12.41, P value= 0.01) from 3-6 kHz in workers below age 22-43. The analysis showed a protective association of the SOD2 Ala/Val genotype (β= -26.42, P value= 0.025) and The GPX1 Leu/Leu genotypes (β=47.81, P value= 0.034) with audiometric thresholds from 3-6 kHz in individuals above age 43. This small cross-sectional study suggests that polymorphisms within the antioxidant system may alter susceptibility to hearing loss in workers exposed to organic solvents. These results also suggest the mechanisms by which this affect are mediated are complex and should be further investigated.

No description available.